The influence of leukoreduction on the acute transfusion‐related complication rate in 455 dogs receiving 730 packed RBCs: 2014–2017
Objective To investigate the influence of prestorage leukoreduction of packed RBCs (pRBCs) on acute transfusion‐related complication rate in dogs. Setting Two private referral hospitals. Design Retrospective case study. Animals Four hundred and fifty‐five dogs receiving nonleukoreduced (nLR) or leuk...
Gespeichert in:
Veröffentlicht in: | Journal of veterinary emergency and critical care (San Antonio, Tex. : 2000) Tex. : 2000), 2022-07, Vol.32 (4), p.479-490 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective
To investigate the influence of prestorage leukoreduction of packed RBCs (pRBCs) on acute transfusion‐related complication rate in dogs.
Setting
Two private referral hospitals.
Design
Retrospective case study.
Animals
Four hundred and fifty‐five dogs receiving nonleukoreduced (nLR) or leukoreduced (LR) pRBC between January 1, 2014 and July 31, 2017.
Measurements and Main Results
Transfusions were retrospectively reviewed to record data about the patient, donor, unit, transfusion event, acute complications, hospital discharge, and cause of death. Of 730 transfusion events in 455 dogs, 288 used LR pRBC and 442 used nLR pRBC. There was a 18.9% (138/730) overall complication rate. Seven (0.96%) complications were life‐threatening. The most common complications were pyrexia (5.6%), gastrointestinal signs (4.9%), and hemolysis with no other signs (4.1%). Pyrexia with no other clinical signs, consistent with a febrile nonhemolytic transfusion reaction (FNHTR), occurred in 3.2% of transfusion events. There was a significant (P = 0.03) decrease in the rate of FNHTR with LR pRBC (1%) versus nLR pRBC (4.5%). Use of LR pRBC did not decrease in‐hospital mortality. The odds of any complication, hemolysis only, FNHTR, and more severe complications increased with pRBC age. Leukoreduction did not decrease the impact of pRBC age on these complications. Use of older pRBC did not increase the incidence of life‐threatening complications or mortality. Dogs receiving pRBC for blood loss were more likely to have gastrointestinal and more severe complications than those dogs that had hemolysis. The effect of pRBC unit age on complications was not influenced by the underlying reason for transfusion. Dogs that received a previous transfusion were more likely to have respiratory complications.
Conclusion
In this study, the use of LR pRBC was associated with a decreased rate of FNHTR but no other complications. Unit age was associated with the incidence of hemolysis, FNHTR, and complication severity but not the rate of life‐threatening complications or mortality. |
---|---|
ISSN: | 1479-3261 1476-4431 |
DOI: | 10.1111/vec.13175 |